Miller Franklin J 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 15, 2019
Insider Transaction Report
Form 4
Miller Franklin J
Director
Transactions
- Exercise/Conversion
Common Stock, No Par Value
2019-03-14$12.91/sh+20,000$258,200→ 34,038 total - Sale
Common Stock, No Par Value
2019-03-14$60.44/sh−20,000$1,208,760→ 14,038 total - Exercise/Conversion
Non-qualified stock options (right to buy)
2019-03-14−20,000→ 0 totalExercise: $12.91From: 2013-05-23Exp: 2019-05-23→ Common Stock (20,000 underlying)
Holdings
- 18,193(indirect: By Trust)
Common Stock, No Par Value
- 25,000
Non-qualified stock options (right to buy)
Exercise: $50.50From: 2019-06-07Exp: 2025-06-07→ Common Stock (25,000 underlying) - 25,000
Non-qualified stock options (right to buy)
Exercise: $9.95From: 2014-05-22Exp: 2020-05-22→ Common Stock (25,000 underlying) - 25,000
Non-qualified stock options (right to buy)
Exercise: $13.99From: 2015-06-11Exp: 2021-06-11→ Common Stock (25,000 underlying) - 25,000
Non-qualified stock options (right to buy)
Exercise: $20.27From: 2016-05-22Exp: 2022-05-22→ Common Stock (25,000 underlying) - 25,000
Non-qualified stock options (right to buy)
Exercise: $18.80From: 2017-05-26Exp: 2023-05-26→ Common Stock (25,000 underlying) - 25,000
Non-qualified stock options (right to buy)
Exercise: $34.40From: 2018-05-24Exp: 2024-05-24→ Common Stock (25,000 underlying)
Footnotes (8)
- [F1]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.25 to $60.73, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F2]Becomes exercisable in equal annual installments of 20% commencing 05/23/2013.
- [F3]Becomes exercisable in equal annual installments of 20% commencing 05/22/2014.
- [F4]Becomes exercisable in equal annual installments of 20% commencing 06/11/2015.
- [F5]Becomes exercisable in equal annual installments of 20% commencing 05/22/2016.
- [F6]Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.
- [F7]Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
- [F8]Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.